Breaking News

Altruist Biologics’ Hangzhou Facility Gets First Commercial-Scale Manufacturing License

It is the first such certificate issued to a 20,000-liter scale biologics facility in China.

Author Image

By: Patrick Lavery

Content Marketing Editor

An Altruist Biologics facility in Hangzhou, China received a Drug Product Manufacturing License from the Chinese National Medical Products Administration. The “C Certificate” is the first awarded to a 20,000-liter scale biologics manufacturing facility in China. For Altruist, a CDMO subsidiary of Innovent Biologics, the certificate confirms the site meets requirements for drug production quality management. These rigorous standards encompass quality systems, good manufacturing practice (GMP) ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters